rs34752197
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001378213.1(BCL9L):āc.1936A>Gā(p.Met646Val) variant causes a missense change. The variant allele was found at a frequency of 0.0115 in 1,610,672 control chromosomes in the GnomAD database, including 398 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.013 ( 53 hom., cov: 32)
Exomes š: 0.011 ( 345 hom. )
Consequence
BCL9L
NM_001378213.1 missense
NM_001378213.1 missense
Scores
18
Clinical Significance
Conservation
PhyloP100: 5.54
Genes affected
BCL9L (HGNC:23688): (BCL9 like) Enables beta-catenin binding activity. Involved in several processes, including negative regulation of transforming growth factor beta receptor signaling pathway; positive regulation of epithelial to mesenchymal transition; and positive regulation of transcription by RNA polymerase II. Located in nucleolus and nucleoplasm. Part of beta-catenin-TCF complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0014236867).
BP6
Variant 11-118901807-T-C is Benign according to our data. Variant chr11-118901807-T-C is described in ClinVar as [Benign]. Clinvar id is 402416.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.105 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCL9L | NM_001378213.1 | c.1936A>G | p.Met646Val | missense_variant | 8/10 | ENST00000683865.1 | NP_001365142.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCL9L | ENST00000683865.1 | c.1936A>G | p.Met646Val | missense_variant | 8/10 | NM_001378213.1 | ENSP00000507778.1 | |||
BCL9L | ENST00000334801.7 | c.1936A>G | p.Met646Val | missense_variant | 6/8 | 1 | ENSP00000335320.3 | |||
BCL9L | ENST00000526143.2 | c.1825A>G | p.Met609Val | missense_variant | 6/8 | 5 | ENSP00000482938.1 | |||
BCL9L | ENST00000530293.1 | n.41-1046A>G | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0127 AC: 1928AN: 152150Hom.: 53 Cov.: 32
GnomAD3 genomes
AF:
AC:
1928
AN:
152150
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0193 AC: 4826AN: 250482Hom.: 208 AF XY: 0.0190 AC XY: 2570AN XY: 135418
GnomAD3 exomes
AF:
AC:
4826
AN:
250482
Hom.:
AF XY:
AC XY:
2570
AN XY:
135418
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0114 AC: 16656AN: 1458404Hom.: 345 Cov.: 36 AF XY: 0.0116 AC XY: 8438AN XY: 724794
GnomAD4 exome
AF:
AC:
16656
AN:
1458404
Hom.:
Cov.:
36
AF XY:
AC XY:
8438
AN XY:
724794
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0126 AC: 1925AN: 152268Hom.: 53 Cov.: 32 AF XY: 0.0149 AC XY: 1111AN XY: 74456
GnomAD4 genome
AF:
AC:
1925
AN:
152268
Hom.:
Cov.:
32
AF XY:
AC XY:
1111
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
26
ALSPAC
AF:
AC:
20
ESP6500AA
AF:
AC:
19
ESP6500EA
AF:
AC:
62
ExAC
AF:
AC:
2140
Asia WGS
AF:
AC:
174
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
PrimateAI
Benign
T
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Benign
T;.
Sift4G
Benign
T;T
Polyphen
B;.
Vest4
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at